Along with similar results in colorectal cancer [143], these data suggest that FRA-1 might contribute to the transactivation of the ITGB4 promoter in invasive breast cancer, as previously shown in undifferentiated basal keratinocytes [144]. This evidence concerns the gene ITGB4 and invasive breast carcinoma.